Beschreibung
In this study many immunological, hematological and virological parameters were evaluated, starting with patient after mastectomy (M) not subjected to any (chemo- or radiotherapy), patients after 3 cycle(a) and patients at the end of 6 cycle(b) of chemotherapy treatment (each cycle lasted 21 days) using protocol CAF (A) and protocol TAC (B) for treatment, 22 patients treated by protocol A and 18 patients treated with protocol B.
Autorenporträt
Awarded Ph.D in 2010 in the field of Medical Immunology, Department of Microbiology, College of Medicine, Hawler Medical University, Erbil, Kurdistan Region, Iraq.
